In this interview, Theodoros Teknos, MD, discusses the results of his current phase I trial of vorinostat (Zolinza) in advanced head and neck cancer.
We spoke with Victoria Miller, FNP-BC, on how to identify and treat cytokine release syndrome in cancer patients being treated with immunotherapy at the Oncology Nursing Society 42nd Annual Congress, held May 4–7 in Denver.
In this podcast interview, Dr. William Wierda discusses the role of venetoclax in treating patients with chronic lymphocytic leukemia, particularly in light of recent trial results.